PB&B

About:

PB&B is a life sciences startup developing a new generation of fillers and soft tissue remodeling injections for plastic surgeons.

Website: http://www.pbbtech.com

Top Investors: Venture Kick, Newchip Accelerator, MassChallenge, Horizon 2020

Description:

PB&B SA is an early-stage Life Sciences company founded in 2013 by bioengineers who teamed up with plastic surgeons & scientists to create natural & minimally invasive solutions for facial aging & body remodeling. PB&B developed an injection to increase adipose (fat) volume in situ using the most advanced microencapsulation & drug delivery technologies. PB&B’s patented technology aims to transform a fast-growing, multi-billion-dollar body shaping market by targeting under-served needs with a simple, fast and safer alternative to fat transfer. Products have been designed for Plastic Surgeons and Aesthetic Injectors active in body shaping procedures for facial, hands, décolleté and buttock enhancement indications.

Total Funding Amount:

$3.31M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Lausanne, Vaud, Switzerland

Founded Date:

2013-01-01

Contact Email:

contact(AT)pbbtech.ch

Founders:

Anthony Aho, Sandeep Raghunathan, Sergio Klinke

Number of Employees:

1-10

Last Funding Date:

2021-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai